VANGUARD GROUP INC 13D and 13G filings for Abbott Laboratories:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:05 pm Sale | 2026-03-13 | 13G | ABBOTT LABS ABT | VANGUARD GROUP INC | 0 0.000% | -174,894,079 (Position Closed) | Filing |
| 2025-12-03 11:02 am Purchase | 2025-11-28 | 13G | ABBOTT LABS ABT | VANGUARD GROUP INC | 174,894,079 10.050% | 18,449,379 (+11.79%) | Filing |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | ABBOTT LABS ABT | VANGUARD GROUP INC | 156,444,700 9.010% | 963,906 (+0.62%) | Filing |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | ABBOTT LABS ABT | VANGUARD GROUP INC | 155,480,794 8.920% | 6,328,530 (+4.24%) | Filing |
| 2022-02-09 3:15 pm Purchase | 2021-12-31 | 13G | ABBOTT LABS ABT | VANGUARD GROUP INC | 149,152,264 8.430% | 1,879,344 (+1.28%) | Filing |